Annual Drug Patent Expirations for TECFIDERA
Tecfidera is a drug marketed by Biogen Idec Inc and is included in one NDA. It is available from two suppliers. There is one patent protecting this drug and one Paragraph IV challenge.
Drug patent litigation for TECFIDERA.
This drug has sixteen patent family members in twelve countries.
The generic ingredient in TECFIDERA is dimethyl fumarate. Two suppliers are listed for this compound. Additional details are available on the dimethyl fumarate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
